Gangat, N., Ilyas, R., McCullough, K., Begna, K. H., Al-Kali, A., Patnaik, M. M., Litzow, M. R., Hogan, W. J., Mangaonkar, A., Alkhateeb, H., Shah, M. V., Elliott, M. A., Foran, J. M., Badar, T., Palmer, J. M., Hanson, C. A., Pardanani, A. and Tefferi, A. (2023) “Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm”, Haematologica. Pavia, Italy, 108(5), pp. 1423-1428. doi: 10.3324/haematol.2022.282019.